Anonymous
Guest
Anonymous
Guest
http://bostonglobe.com/business/201...ith-complex/M3oy28fCBuaxzXjJ6HrmSK/story.html
because you know......they have to "CUT COSTS"
In a part of Cambridge filled with hulking science labs, Swiss medical giant Novartis AG is building a striking glass and granite building designed by noted architect Maya Lin.
Lin is among several prominent designers Novartis hired to create a $600 million three-building laboratory and office complex that will be the centerpiece of its worldwide research operations based in Cambridge.
Cambridge’s $600m project
Clad in glass, terra cotta, and granite, the complex will also include retail shops to fill in a large hole in the commercial strip along Massachusetts Avenue, as well as a 1.35-acre park adjacent to the Massachusetts Institute of Technology.
Lin’s concept is a building that gradually rises along Massachusetts Avenue, with a main entry and an interior courtyard filled with trees and meandering pathways.
“I wanted this to feel not like an isolated island, but something penetrable for everyone from MIT to walk around,’’ said Mark Fishman, the president of the company’s Institutes for Biomedical Research.
“We want people to mix there just as they would at a university.’’
The Lin and other buildings were approved by the Cambridge Planning Board Tuesday night. Novartis has already begun site work on the property and expects to complete the complex in 2015.
because you know......they have to "CUT COSTS"
In a part of Cambridge filled with hulking science labs, Swiss medical giant Novartis AG is building a striking glass and granite building designed by noted architect Maya Lin.
Lin is among several prominent designers Novartis hired to create a $600 million three-building laboratory and office complex that will be the centerpiece of its worldwide research operations based in Cambridge.
Cambridge’s $600m project
Clad in glass, terra cotta, and granite, the complex will also include retail shops to fill in a large hole in the commercial strip along Massachusetts Avenue, as well as a 1.35-acre park adjacent to the Massachusetts Institute of Technology.
Lin’s concept is a building that gradually rises along Massachusetts Avenue, with a main entry and an interior courtyard filled with trees and meandering pathways.
“I wanted this to feel not like an isolated island, but something penetrable for everyone from MIT to walk around,’’ said Mark Fishman, the president of the company’s Institutes for Biomedical Research.
“We want people to mix there just as they would at a university.’’
The Lin and other buildings were approved by the Cambridge Planning Board Tuesday night. Novartis has already begun site work on the property and expects to complete the complex in 2015.